Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Pulmonary Fibrosis and AGER[original query] |
---|
Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis. Annals of the American Thoracic Society 2017 Mar . Manichaikul Ani, Sun Li, Borczuk Alain C, Onengut-Gumuscu Suna, Farber Emily A, Mathai Susan K, Zhang Weiming, Raghu Ganesh, Kaufman Joel D, Hinckley-Stukovsky Karen D, Kawut Steven M, Jelic Sanja, Liu Wen, Fingerlin Tasha E, Schwartz David A, Sell Jessica L, Rich Stephen S, Barr R Graham, Lederer David |
AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis. Respirology (Carlton, Vic.) 2017 Feb . Yamaguchi Kakuhiro, Iwamoto Hiroshi, Horimasu Yasushi, Ohshimo Shinichiro, Fujitaka Kazunori, Hamada Hironobu, Mazur Witold, Kohno Nobuoki, Hattori Nobo |
The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients. Scientific reports 2020 Jul 10 (1): 12811. Kinjo Takumi, Kitaguchi Yoshiaki, Droma Yunden, Yasuo Masanori, Wada Yosuke, Ueno Fumika, Ota Masao, Hanaoka Masayu |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: